Abbott Laboratories (ABT) — Stock Valuation & Research

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm,…

ABT key statistics

Price$102.52
Market cap$177.4B
SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE
52-week range81.97-137.49
Dividend (TTM)$2.48 per share
Beta0.59

Explore ABT's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.